Research Roundup: Patient-centric TB treatment, Mpox vaccine trial, Long-lasting flu drug
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
As the U.S. Food and Drug Administration (FDA) faces significant staffing reductions, there could be ripple effects for US companies and leadership in the biomedical space, as well as for other countries that depend on the FDA's regulatory leadership to enable access to essential health technologies.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.